Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections

被引:130
作者
Ghosh, A [1 ]
Zhang, WW [1 ]
Matlashewski, G [1 ]
机构
[1] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada
基金
加拿大健康研究院;
关键词
vaccine; Leishmania donovani; macrophage;
D O I
10.1016/S0264-410X(01)00322-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The A2 genes of Leishmania donovani encode amastigote-specific A2 proteins, which are considered to be virulence factors required for the survival of this protozoan parasite in the mammalian host. The A2 genes are present within a multigene family and corresponding A2 proteins are composed predominantly of multiple copies of a 10 amino acid repeat sequences. A2-specific antibodies have been detected in the sera of patients suffering from visceral leishmaniasis (VL) and it has been shown that generation of A2 deficient L. donovani resulted in an avirulent phenotype. In this report, we show that immunization of mice with recombinant A2 protein conferred significant protection against challenge infection with L. donovani. The protection correlated with in vitro splenocyte proliferation, production of IFN-gamma in response to A2 protein and the presence of A2-specific antibodies in the sera of immunized mice. These data demonstrate that A2 represents a potential antigen for protection against infection with L. donovani and VL. (C) 2001 Published by Elsevier Science Ltd.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 59 条
[11]   Visceral leishmaniasis in clinical practice [J].
Davidson, RN .
JOURNAL OF INFECTION, 1999, 39 (02) :112-116
[12]   Immunization with recombinant LD1 antigens protects against experimental leishmaniasis [J].
Dole, VS ;
Raj, VS ;
Ghosh, A ;
Madhubala, R ;
Myler, PJ ;
Stuart, KD .
VACCINE, 2000, 19 (4-5) :423-430
[13]   Immune adherence-mediated opsonophagocytosis:: The mechanism of Leishmania infection [J].
Domínguez, M ;
Toraño, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) :25-35
[14]   Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus iscoms [J].
Dotsika, E ;
Karagouni, E ;
Sundquist, B ;
Morein, B ;
Morgan, A ;
VillacresEriksson, M .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 45 (03) :261-268
[15]   EVALUATION OF ANTIBODY-RESPONSES IN AMERICAN VISCERAL LEISHMANIASIS BY ELISA AND IMMUNOBLOT [J].
EVANS, TG ;
KRUG, EC ;
WILSON, ME ;
VASCONCELOS, AW ;
DEALENCAR, JE ;
PEARSON, RD .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1989, 84 (02) :157-166
[16]  
GALVAOCASTRO B, 1984, CLIN EXP IMMUNOL, V56, P58
[17]   Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis [J].
Ghedin, E ;
Zhang, WW ;
Charest, H ;
Sundar, S ;
Kenney, RT ;
Matlashewski, G .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (05) :530-535
[18]   Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major [J].
Gurunathan, S ;
Sacks, DL ;
Brown, DR ;
Reiner, SL ;
Charest, H ;
Glaichenhaus, N ;
Seder, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1137-1147
[19]   COMPARISON OF RECEPTORS REQUIRED FOR ENTRY OF LEISHMANIA-MAJOR AMASTIGOTES INTO MACROPHAGES [J].
GUY, RA ;
BELOSEVIC, M .
INFECTION AND IMMUNITY, 1993, 61 (04) :1553-1558
[20]   RECIPROCAL EXPRESSION OF INTERFERON-GAMMA OR INTERLEUKIN-4 DURING THE RESOLUTION OR PROGRESSION OF MURINE LEISHMANIASIS - EVIDENCE FOR EXPANSION OF DISTINCT HELPER T-CELL SUBSETS [J].
HEINZEL, FP ;
SADICK, MD ;
HOLADAY, BJ ;
COFFMAN, RL ;
LOCKSLEY, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) :59-72